mito-extra® - medac GmbH

62
Okamura K, Ono Y, Kinukawa T, Matsuura O, Yamada S, Ando T, Fukatsu T,
Ohno Y, Ohshima S
Randomized Study of Single Early Instillation of (2"R)-4'-0-Tetrahydropyranyl-
Doxorubicin for a Single Superficial Bladder Carcinoma
Cancer 2002; 94: 2363-2368
Oosterlinck W, Kurth KH, Schröder FH, et al.
A prospective european organisation for research and treatment of cancer genitourinary
group randomized trial comparing transurethral resection followed by a
single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary
carcinoma of the bladder
J-Urol, 1993; 149: 749-752
Oosterlinck W, Lobel B, Jakse G, Malmström PU, Stöckle M, Sternberg C,
EAU Working Group on Oncological Urology
Guidelines on Bladder Cancer\NLN\
Eur-Urol, 2002; 41: 105-112
Pan JS, Slocum HK, Rustum YM, Greco WR, Gaeta JF, Huben RP,
Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder
J-Urol, 1989; 142: 1589-1593
Patel A, Fuchs GJ,
New techniques for the administration of topical adjuvant therapy after endoscopic
ablation of upper urinary tract transitional cell carcinoma
J-Urol 1998; 159: 71-75
Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I
Noninvasive detection of bladder cancer with the BTA stat test
J-Urol, 1999; 161: 443-446
Prout GR Jr, Griffin PP, Nocks BN, DeFuria MD, Daly JJ.
Intravesical therapy of low stage bladder carcinoma with Mitomycin: comparison
of results in untreated and previously treated patients.
J Urol. 1982; 127(6):1096-8
Rajala P, Kaasinen E, Raitanen M, Liukkonen T, Rintala-E, Finnbladder
Group
Perioperative single dose instillation of epirubicin or interferon-alpha after transurethral
resection for the prophylaxis of primary superficial bladder cancer recurrence:
A prospective randomized multicenter study- Finnbladder III long-term
results
J-Urol 2002; 168: 981-985
Ramanathan-Girish S, M Boroujerdi
Contradistinction between doxorubicin and epirubicin: in-vitro interaction with
blood components.
J Pharm Pharmacol, June 1, 2001; 53(6): 815-21.
Rimpler, H.
Pharmazeutische Biologie II: Biogene Arzneistoffe; G. Thieme Verlag Stuttgart,
1. Auflage, 1990, S. 622
Rintala E, Jauhiainen K, Kaasinen E, Nurmi M, Alfthan O
Alternating MMC and BCG instillation prophylaxis for recurrent papillary (stage Ta
- T1) superficial bladder cancer
J-Urol 1996: Vol. 156, 56-60
Rübben H, Lutzeyer W, et al.
Natural History and the Treatment of low and high risk Superficial Bladder
Tumors
J Urol 1988; 139: 283-285
Schwaibold H, Pichlmeier U, Klingenberger HJ, Huland H
Long-Term Follow-Up of Cytostatic Intravesical Instillation in Patients with
Superficial Bladder Carcinoma
Eur-Urol, 1997; 31: 153-159